BRIEF-Shenzhen Hepalink Pharma's 2016 net profit down, share trade to halt pending announcement

April 27 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says 2016 net profit down 31.5 percent y/y at 396.9

million yuan ($57.59 million)

* Says trading in shares to halt from April 28 pending

announcement related to asset acquisition

Source text in Chinese: ;

Further company coverage:

($1 = 6.8920 Chinese yuan renminbi)

(Reporting by Hong Kong newsroom)